Detecting Clostridium botulinum.To the Editor: In the October 2005 issue of Emerging Infectious Diseases, Song et al. described a fiber-optic, microsphere-based, high-density array composed of 18 species-specific probe microsensors, used to identify biological warfare agents, including Clostridium botulinum (1). Although the researchers used multiple probes for C. botulinum bot·u·li·num or bot·u·li·nus n. An anaerobic, rod-shaped bacterium (Clostridium botulinum) that secretes botulin and inhabits soils. , we doubt that this approach is suitable for this organism. C. botulinum comprises a heterogenous (spelling) heterogenous - It's spelled heterogeneous. group of subspecies subspecies, also called race, a genetically distinct geographical subunit of a species. See also classification. that produce botulinum neurotoxin neurotoxin /neu·ro·tox·in/ (noor´o-tok?sin) a substance that is poisonous or destructive to nerve tissue. neu·ro·tox·in n. See neurolysin. (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism botulism (bŏch`əlĭz'əm), acute poisoning resulting from ingestion of food containing toxins produced by the bacillus Clostridium botulinum. , some strains of C. butyricum and C. baratii are also able to produce BoNTs. The mouse bioassay Bioassay A method for the quantitation of the effects on a biological system by its exposure to a substance, as well as the quantitation of the concentration of a substance by some observable effect on a biological system. is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose Minimum lethal dose (MLD, also LDmin) is the least amount of drug that can produce death in a given animal species under controlled conditions. Related Concept
Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4). References (1.) Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:1629-32. (2.) Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:313-20. (3.) Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay enzyme-linked immunosorbent assay n. ELISA. Enzyme-linked immunosorbent assay (ELISA) A diagnostic blood test used to screen patients for AIDS or other viruses. procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:203-6. (4.) BaIT JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578-83. Address for correspondence: Franz Allerberger, Medical University Innsbruck, Department of Hygiene, Fritz Pregl Str 3, Innsbruck Austria 6020; email: Franz. Allerberger@i-med.ac.at Josef Karner * and Franz Allerberger * * Medical University Innsbruck, Innsbruck, Austria |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion